Related Experiment Video
Updated: May 4, 2026

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
Waldenstrom's Macroglobulinaemia Presenting as Demyelinating Polyradiculoneuropathy
S A W Fadilah1, A A Raymond, I Najihah
1Mater Medical Research Institute (MMRI), Aubigny Place, Raymond Tee, South Brisbane, Queensland 4101, Australia. fabdulwahid@mmri.mater.org.au.
Abstract:
Patients (particularly elderly) undergoing evaluation for peripheral neuropathy of unknown cause should be screened for the presence of a monoclonal protein (M protein). The association of a neuropathy and a paraproteinaemia such as Waldenstrom's Macroglobulinaemia (WM) is not uncommon with the former antedating the haematologic symptoms by several years. Response to treatment has varied from good to very poor. We describe a case of WM presenting as a subacute demyelinating peripheral neuropathy. There was prompt resolution of the neuropathy with intravenous immunoglobulin therapy. Subsequent treatment with cyclophosphamide and plasmapheresis resulted in complete clinical remission with no further neurological relapses.
Insights
Screening elderly patients with unknown peripheral neuropathy for monoclonal proteins is crucial. Early detection of Waldenstrom
Area of Science:
- Neurology
- Hematology
- Oncology
Background:
- Peripheral neuropathy is a common neurological disorder, particularly in the elderly.
- Monoclonal gammopathies, including Waldenstrom's Macroglobulinaemia (WM), can be associated with peripheral neuropathy.
- The neurological symptoms may precede the hematological diagnosis of WM by several years.
Observation:
- A case of subacute demyelinating peripheral neuropathy was observed.
- This neuropathy was associated with Waldenstrom's Macroglobulinaemia.
- The patient presented with neurological symptoms prior to the hematological diagnosis.
Findings:
- Prompt resolution of peripheral neuropathy occurred following intravenous immunoglobulin therapy.
- Subsequent treatment with cyclophosphamide and plasmapheresis led to complete clinical remission.
- No further neurological relapses were observed after treatment.
Implications:
- Highlights the importance of screening for monoclonal proteins in elderly patients with unexplained peripheral neuropathy.
- Suggests that early detection and treatment of WM-associated neuropathy can lead to favorable outcomes.
- Demonstrates the efficacy of a multi-modal treatment approach including immunotherapy and chemotherapy for WM-related neurological complications.
More Related Videos
07:30A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
Related Concept Videos
Multiple Sclerosis l: Introduction
Encephalitis ll: Pathophysiology
Arboviral Encephalitis
Myasthenia Gravis ll: Pathophysiology